These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 8980781)

  • 1. Isolation and characterization of fluconazole- and amphotericin B-resistant Candida albicans from blood of two patients with leukemia.
    Nolte FS; Parkinson T; Falconer DJ; Dix S; Williams J; Gilmore C; Geller R; Wingard JR
    Antimicrob Agents Chemother; 1997 Jan; 41(1):196-9. PubMed ID: 8980781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluconazole resistance of Candida krusei.
    Manso E; Montillo M; Discepoli G; Leoni P
    Boll Ist Sieroter Milan; 1991-1992; 70(1-2):527-9. PubMed ID: 1670057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome-wide expression profiling reveals genes associated with amphotericin B and fluconazole resistance in experimentally induced antifungal resistant isolates of Candida albicans.
    Barker KS; Crisp S; Wiederhold N; Lewis RE; Bareither B; Eckstein J; Barbuch R; Bard M; Rogers PD
    J Antimicrob Chemother; 2004 Aug; 54(2):376-85. PubMed ID: 15201233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation between in vitro and in vivo activity of antifungal agents against Candida species.
    Anaissie EJ; Karyotakis NC; Hachem R; Dignani MC; Rex JH; Paetznick V
    J Infect Dis; 1994 Aug; 170(2):384-9. PubMed ID: 8035024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breakthrough fungemia caused by azole-resistant Candida albicans in neutropenic patients with acute leukemia.
    Myoken Y; Kyo T; Kohara T; Fujihara M; Sugata T; Mikami Y
    Clin Infect Dis; 2003 Jun; 36(11):1496-7. PubMed ID: 12766847
    [No Abstract]   [Full Text] [Related]  

  • 6. A randomized study comparing fluconazole with amphotericin B/5-flucytosine for the treatment of systemic Candida infections in intensive care patients.
    Abele-Horn M; Kopp A; Sternberg U; Ohly A; Dauber A; Russwurm W; Büchinger W; Nagengast O; Emmerling P
    Infection; 1996; 24(6):426-32. PubMed ID: 9007589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical applicability of antifungal susceptibility testing on non-Candida albicans species in hospitalized patients.
    Wong-Beringera A; Hindler J; Brankovic L; Muehlbauer L; Steele-Moore L
    Diagn Microbiol Infect Dis; 2001 Jan; 39(1):25-31. PubMed ID: 11173188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacies of high-dose fluconazole plus amphotericin B and high-dose fluconazole plus 5-fluorocytosine versus amphotericin B, fluconazole, and 5-fluorocytosine monotherapies in treatment of experimental endocarditis, endophthalmitis, and pyelonephritis due to Candida albicans.
    Louie A; Liu W; Miller DA; Sucke AC; Liu QF; Drusano GL; Mayers M; Miller MH
    Antimicrob Agents Chemother; 1999 Dec; 43(12):2831-40. PubMed ID: 10582868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [INVESTIGATION ON ANTIFUNGAL SUSCEPTIBILITY OF CANDIDA YEASTS IN PREGNANT PATIENTS WITH CONFIRMED VULVOVAGINAL CANDIDIASIS AND THEIR NEWBORNS.].
    Chokoeva A; Kouzmanov A; Ivanova Z; Zisova L; Amalie G; Petleshkova P; Miteva-Katrandzhieva T; Krasteva M; Uchikova E
    Akush Ginekol (Sofiia); 2016; 55(4):20-29. PubMed ID: 29370489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post-antifungal effect of polyene, azole and DNA-analogue agents against oral Candida albicans and Candida tropicalis isolates in HIV disease.
    Anil S; Ellepola AN; Samaranayake LP
    J Oral Pathol Med; 2001 Sep; 30(8):481-8. PubMed ID: 11545239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of albicans and non-albicans candiduria in a Malaysian medical centre.
    Ding CH; Wahab AA; Muttaqillah NA; Tzar MN
    J Pak Med Assoc; 2014 Dec; 64(12):1375-9. PubMed ID: 25842581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation of fluconazole-resistant Candida albicans from human immunodeficiency virus-negative patients never treated with azoles.
    Goff DA; Koletar SL; Buesching WJ; Barnishan J; Fass RJ
    Clin Infect Dis; 1995 Jan; 20(1):77-83. PubMed ID: 7727675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of fluconazole in prophylaxis and treatment of experimental Candida endocarditis.
    Longman LP; Hibbert SA; Martin MV
    Rev Infect Dis; 1990; 12 Suppl 3():S294-8. PubMed ID: 2184507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Community-acquired fungemia due to a multiple-azole-resistant strain of Candida tropicalis.
    Jandourek A; Brown P; Vazquez JA
    Clin Infect Dis; 1999 Dec; 29(6):1583-4. PubMed ID: 10585825
    [No Abstract]   [Full Text] [Related]  

  • 15. Phenotypic variation and antifungal susceptibility patterns of Candida albicans strains isolated from neutropenic patients.
    Kiraz N; Anğ O; Akgün Y; Erturan Z
    Mycoses; 2000; 43(3-4):119-23. PubMed ID: 10907341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of antifungal therapy on inflammation, sterilization, and histology in experimental Candida albicans meningitis.
    Jafari HS; Sáez-Llorens X; Severien C; Parras F; Friedland I; Rinderknecht S; Ehrett S; Olsen KD; Abramowsky C; McCracken GH
    Antimicrob Agents Chemother; 1994 Jan; 38(1):83-9. PubMed ID: 7511361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antifungal susceptibility of 262 bloodstream yeast isolates from a mixed cancer and non-cancer patient population: is there a correlation between in-vitro resistance to fluconazole and the outcome of fungemia?
    Kovacicova G; Krupova Y; Lovaszova M; Roidova A; Trupl J; Liskova A; Hanzen J; Milosovic P; Lamosova M; Macekova L; Szovenyiova Z; Purgelova A; Obertik T; Bille J; Krcmery V
    J Infect Chemother; 2000 Dec; 6(4):216-21. PubMed ID: 11810569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro susceptibility of Candida albicans, Austria 1992.
    Allerberger F; Fassl A; Niederwieser D; Zangerle R; Lingnau W; Dierich MP
    Mycoses; 1993; 36(11-12):411-6. PubMed ID: 7935573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resistance to fluconazole and amphotericin B in a patient with AIDS who was being treated for candidal esophagitis.
    Le TP; Tuazon CU; Levine M; Borum M; Rollhauser C
    Clin Infect Dis; 1996 Sep; 23(3):649-50. PubMed ID: 8879803
    [No Abstract]   [Full Text] [Related]  

  • 20. Amino acid substitutions in the Candida albicans sterol Δ5,6-desaturase (Erg3p) confer azole resistance: characterization of two novel mutants with impaired virulence.
    Morio F; Pagniez F; Lacroix C; Miegeville M; Le Pape P
    J Antimicrob Chemother; 2012 Sep; 67(9):2131-8. PubMed ID: 22678731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.